auris surgical robotics is a technology company based in silicon valley

About Us

Auris is redefining the future of medical intervention. By combining advancements in medical robotics, instrumentation, navigation and data science, the company is building a platform technology capable of expanding the applicability of robotics to a broad spectrum of medical procedures.

Board of Directors

Dr. Fred Moll

Frederic H. Moll, M.D. is the co-founder and CEO of Auris Surgical Robotics. Prior to Auris, Dr. Moll co-Founded Hansen Medical and served as the company's Chief Executive Officer from 2002 - 2010. Previously, Dr. Moll Co-founded Intuitive Surgical Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director. Dr. Moll Co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, a medical device company, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant's Surgical Device Division until November 1995.

Ajay Royan

Ajay co-founded Mithril in 2012 and leads the firm as its Managing General Partner. He was formerly Managing Director and Senior Investor at Clarium, where he led unlevered growth investments. He co-founded Breakout Labs, has been a recurring guest lecturer on macro investing at Yale, and serves as an external adviser to Oak Ridge National Laboratory and the University of Michigan Risk Science Center. He earned a B.A. from Yale.

Peter Hébert

Peter is co-founder of Lux Capital and focuses on investments in technology and energy. Peter began his career at Lehman Brothers, where he worked in the firm's top-ranked Equity Research group. In 2000, he co-founded Lux Capital. In 2003, Peter led the spin-off of Lux Research. As founding CEO, he helped build Lux Research into the leading emerging technology research firm. Peter launched the publicly-listed Lux Nanotech Index (AMEX: LUXNI) and the $150 million PowerShares Lux Nanotech Portfolio (NYSE: PXN).

Dr. Bijan Salehizadeh

Dr. Salehizadeh has over 15 years of healthcare operating and investment experience. Prior to co-founding NaviMed Capital, he was a General Partner at Highland Capital Partners, where he focused on growth stage healthcare investments. Prior to joining Highland Capital Partners in 2003, Dr. Salehizadeh spent several years in a variety of operational roles at Medtronic. Before Medtronic, Dr. Salehizadeh held a variety of senior management roles with HealthCentral, a private equity-backed digital health company that went public in 1999. Dr. Salehizadeh holds an AB in Molecular Biology from Princeton University, an MD and Master’s in Science in Health Policy from Columbia University, and an MBA from Harvard Business School. He is also a graduate of the Kauffman Fellows Program.